FREEDOM

Hazard statements (CLP)

H317, H351, H400, H410

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Warning

Contains

folpet (ISO); N-(trichloromethylthio)phthalimide

Hazard statements

H317 - May cause an allergic skin reaction. H351 - Suspected of causing cancer. H410 - Very toxic to aquatic life with long lasting effects.

Precautionary statements

P102 - Keep out of reach of children. P201 - Obtain special instructions before use. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH208 - Contains folpet (ISO); N-(trichloromethylthio)phthalimide(133-07-3), methenamine; hexamethylenetetramine(100-97-0). May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Hazardous to the aquatic environment – Acute Hazard, Category 1 H400 Hazardous to the aquatic environment – Chronic Hazard, Category 1 H410 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available